Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer

Дата публикации: 10-07-2026 12:40:03

A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in collaboration with the Korea Institute of Science and Technology (KIST) and Incheon National University, has developed a next-generation anticancer immunotherapy technology that targets and eliminates key substances released by cancer cells while simultaneously boosting the patient's immune response.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer	5	7	09-07-2026
2	Reversible genetic switches could give cancer immunotherapy more precise control	0	6.91	14-10-2026
3	حقنة جديدة تبعث الأمل.. علاج واعد يقضي على أورام السرطان	7	8	01-06-2026
4	Blood-camouflaged nanoparticles defeat drug-resistant breast tumors in mouse model	0	17.59	21-08-2026
5	Antibody screening approach could speed development of immune-based cancer treatments	0	14.96	15-10-2026
6	В Израиле разработали нанометод для борьбы с тройным негативным раком груди	5	7	25-06-2026
7	Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells	0	8.03	24-07-2026
8	Researchers discover novel SRV2 envelope protein for efficient CAR immune cell production	5	7	01-07-2026
9	В РАН рассказали о борьбе с раком посредством клеток, помогающих опухоли расти	0	0	27-08-2019
10	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.